Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/1991
05/15/1991CA2029714A1 Antiidiotypic monoclonal antibodies
05/14/1991WO1991007664A1 Diagnostic proteins to test for more than one antibody
05/14/1991WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991WO1991007492A1 Monoclonal antibodies
05/14/1991WO1991007482A1 Type-b rotavirus cultures and uses thereof
05/14/1991WO1991007434A1 Control of milk secretion
05/14/1991WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991US5015728 Reaction of endopepsidase and insulin, genetic engineering
05/14/1991US5015574 Genetic engineering
05/14/1991US5015568 Quantitative analysis of antibodies and antigens for b-cells
05/14/1991CA2068520A1 Type-b rotavirus cultures and uses thereof
05/14/1991CA2068515A1 Control of milk secretion
05/14/1991CA2045524A1 Diagnostic proteins to test for more than one antibody
05/14/1991CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991CA2029766A1 Polypeptide compound and a process for preparation thereof
05/14/1991CA1284119C Expression method using recombinant bombyx mori nuclear polyhedrosis virus dna
05/10/1991CA2002811A1 Method and kit for evaluating protection to bee venom
05/08/1991WO1991006649A1 Mouse antibody v-region gene fragment and preparation of chimera antibody by using said gene fragment
05/08/1991WO1991006305A1 Oligomeric immunoglobulins
05/08/1991EP0426458A2 Human monocyte growth factor
05/08/1991EP0425661A1 A new method for tapping the immunological repertoire
05/08/1991EP0425549A1 Novel proteins, dna coding for said proteins, and their use
05/08/1991EP0425536A1 Nonglycosylated human interleukin-3 compositions
05/08/1991EP0425482A1 Human insulin analogs and preparations containing them.
05/08/1991CN1051200A Improved process for production of a-21978c derivatives
05/08/1991CN1051199A Modified biological material
05/08/1991CA2045150A1 Oligomeric immunoglobulins
05/08/1991CA2044578A1 Mouse antibody v region gene fragments and method of chimeric antibody preparation using said gene fragments
05/08/1991CA2029457A1 Modified forms of human erythropoietin and dna sequences encoding genes which can express them
05/07/1991US5013662 Bacterial methionine n-terminal peptidase
05/07/1991US5013550 Antibiotics called "chloropolysporins B and C", a process for their preparation, and their therapeutic and veterinary use
05/07/1991CA2029289A1 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them
05/04/1991WO1991006627A1 Nested-cone separator
05/04/1991CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/04/1991CA2072141A1 Nested-cone separator
05/02/1991WO1991005871A1 Bispecific heteroantibodies with dual effector functions
05/02/1991WO1991005867A1 Erythropoietin isoforms
05/02/1991WO1991005866A1 Novel expression systems utilizing bacteriophage t7 promoters and gene sequences
05/02/1991WO1991005864A1 Production of genetically-engineered vaccines for aids and other retroviral diseases
05/02/1991WO1991005862A1 cDNA FRAGMENT CODING THE ALPHA INTERFERON RECEPTOR GENE AND PROCESS FOR THE PREPARATION OF A CORRESPONDING PROTEIN
05/02/1991WO1991005855A1 Modified biological material
05/02/1991WO1991005853A1 Growth hormone antagonists
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991WO1991005800A1 ANTI-RhD HETEROANTIBODIES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
05/02/1991WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991004273A3 Novel peptides associated with the cd4 binding region of gp120 and their methods of use
05/02/1991EP0425082A1 Bordetella vaccines
05/02/1991EP0424990A1 The manufacture and expression of large structural genes
05/02/1991EP0424771A1 Plasmids and hosts for the expression of INA protein (ice nucleating protein)
05/02/1991EP0424748A1 Synthetic envelope peptides of HTLV-I
05/02/1991EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship.
05/02/1991EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor
05/02/1991EP0424429A1 New expression vectors
05/02/1991EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
05/02/1991EP0205564B1 Method for the production of erythropoietin
05/02/1991CA2067235A1 Modified biological material
05/02/1991CA2042577A1 Osteogenic devices
05/01/1991WO1991006652A1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
05/01/1991WO1991006651A1 Gene conferring salt tolerance
05/01/1991WO1991006641A1 Enhancement of cell growth by expression of a cloned hemoglobin gene
05/01/1991WO1991006637A1 Subtilisin mutants
05/01/1991CA2072149A1 Enhancement of cell growth by expression of a cloned hemoglobin gene
05/01/1991CA2070395A1 Gene conferring salt tolerance
05/01/1991CA2027317A1 Vaccine composition with non-immunosuppressive t-cell epitope component
04/1991
04/30/1991US5011915 Centrifuging yeast membrane extract, then diafiltation in guanidine hydrochloride solution, solubilizing with denaturing agent and reducing agent
04/30/1991US5011912 Calcium-dependent affinity for selected peptide terminal sequence
04/30/1991US5011773 Human esterase D, its uses and a process of purification
04/30/1991CA1283750C Platinum co-ordination compounds
04/30/1991CA1283602C Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
04/28/1991WO1991006650A1 C1 inhibitor muteins and uses thereof
04/28/1991WO1991006572A1 Diagnosis of glomerulonephritis
04/28/1991WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2071871A1 C1 inhibitor muteins and uses thereof
04/28/1991CA2071530A1 Diagnosis of glomerulonephritis
04/28/1991CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2028517A1 Enhancement of porcine somatotropin activity
04/26/1991WO1991006677A1 Receptor infection assay
04/26/1991WO1991006673A1 ISOLATING OF STRAINS OF SACCHAROMYCES CEREVISIAE HAVING ALTERED Nα-ACETYLTRANSFERASE ACTIVITY
04/26/1991WO1991006636A1 Identification of methionine n-alpha-acetyltransferase
04/26/1991CA2071486A1 Isolating of strains of saccharomyces cerevisiae having altered n.alpha.-acetyltransferase activity
04/26/1991CA2067757A1 Identification of methionine n-alpha-acetyltransferase
04/26/1991CA2067216A1 Receptor infection assay
04/26/1991CA2027852A1 Food additives
04/25/1991WO1991006647A1 Gastrin releasing peptide receptor
04/25/1991WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2067821A1 Infective drug delivery system using recombinant retroviral vectors
04/25/1991CA2067766A1 Gastrin releasing peptide receptor
04/24/1991EP0424351A2 Modified heparin cofactor II
04/24/1991EP0424117A1 Yeast promoter
04/24/1991EP0424107A1 A novel tumor-associated antigen
04/24/1991EP0424051A1 Glycopeptide antibiotics
04/24/1991EP0424027A1 Vectors for generating transgenic fowl
04/24/1991EP0423980A1 Stem cell factor
04/24/1991EP0423938A1 Ligand-containing medium for chromatographic separation, process for preparing the medium, and use of the medium for isolating synthetic or natural molecules from a fluid mixture
04/24/1991EP0423890A2 Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant DNA technology
04/24/1991EP0423869A1 Infectious bronchitis virus vaccine
1 ... 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 ... 1125